PMID: 6166941May 1, 1981Paper

Target cell specificity of two species of human interferon-alpha produced in Escherichia coli and of hybrid molecules derived from them

Proceedings of the National Academy of Sciences of the United States of America
M StreuliC Weissmann

Abstract

Plasmids containing cDNAs for human interferon (IfN) alpha-1, IFN alpha-2, and several hybrids of the two cDNAs, all joined identically to an Escherichia coli lac promoter fragment gave rise, in E. coli, to fused interferons (fIFNs) that had very different target-cell specificities. fIFN alpha-1 had a lower specific activity on human WISH cells than on bovine MDBK cells, while fIFN alpha-2 showed the opposite behavior. fIFN hybrids with the NH2-proximal half of fIFN alpha-2 behaved qualitatively like fIFN alpha-1, and those with the NH2-proximal half of fIFN alpha-2, behaved like fIFN alpha-2. On mouse L929 cells, fIFN alpha-2 was almost inactive, while fIFN alpha-1 showed relatively high activity. In this case, the fIFN hybrids with the COOH-proximal half of IFN alpha-1 showed activity on mouse cells, while the reciprocal hybrid did not. In many cases, the activity spectrum of the hybrids was very different from that of either parent. We propose that the IFN molecule has either two binding sites or two regions constituting the binding site, one in the COOH- and the other in the NH2-proximal half. The experimental findings can be accounted for if the fits of the two sites to their receptor counterparts on different cell lines a...Continue Reading

References

Oct 25, 1979·Nucleic Acids Research·N M WilkieC Weissmann
May 30, 1978·Biochemical and Biophysical Research Communications·W W de JongL H Cohen
Nov 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·K BackmanW Gilbert
Jul 1, 1974·European Journal of Biochemistry·W M Bonner, R A Laskey
Sep 19, 1980·Science·M G MasucciC Weissmann
Feb 1, 1981·Journal of Interferon Research·S NagataC Weissmann
Dec 11, 1980·Nucleic Acids Research·A M FrischaufH Lehrach

❮ Previous
Next ❯

Citations

Jan 1, 1987·Cancer Metastasis Reviews·M Shearer, J Taylor-Papadimitriou
Jun 15, 1989·Experientia·K E MogensenP Eid
Jan 1, 1994·Biulleten' eksperimental'noĭ biologii i meditsiny·A V DanilkovichG T Sukhikh
Jul 1, 1992·Molecular Immunology·P KontsekV A Maiorov
Jan 1, 1984·Pharmacology & Therapeutics·K C Zoon, H Arnheiter
Jan 1, 1985·Pharmacology & Therapeutics·P B Fisher, S Grant
Jan 1, 1985·Pharmacology & Therapeutics·J A Langer, S Pestka
Nov 1, 1991·Pharmacology & Therapeutics·O R Colamonici, L M Pfeffer
Jun 1, 1995·Pharmacology & Therapeutics·M A Horisberger, S Di Marco
May 1, 1987·Veterinary Immunology and Immunopathology·S W Russell, J L Pace
Jul 1, 1994·Antiviral Research·J D GangemiJ W Kreider
Jan 1, 1990·International Journal of Immunopharmacology·H MatsumuraM Nakano
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·S D PutneyP R Schimmel
Sep 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·R M LawnD V Goeddel
Jul 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·E De MaeyerK Atherton
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·P SlocombeD C Burke
Aug 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·R FukunagaS Nagata
Feb 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S K AckermanK Zoon
May 11, 1991·Proceedings of the National Academy of Sciences of the United States of America·P N RedlichS E Grossberg
Jan 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·E Ishizaka-IkedaS Nagata
Jan 1, 1984·Biotechnology & Genetic Engineering Reviews·M D Edge, R Camble
Dec 19, 2001·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·H TölöJ Parkkinen
Nov 5, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·K E MogensenG Uzé
Jan 1, 1983·Journal of Interferon Research·E De Maeyer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.